My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 275

    1.

    Estrogen, progesterone and epithelial ovarian cancer.

    Ho SM.

    Reprod Biol Endocrinol. 2003 Oct 7;1:73. Review.PMID: 14577831 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells.

    Mukherjee K, Syed V, Ho SM.

    Oncogene. 2005 Jun 23;24(27):4388-400.PMID: 15806153 [PubMed - indexed for MEDLINE]Related articles

    3.

    Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.

    Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM.

    Cancer Res. 2001 Sep 15;61(18):6768-76.PMID: 11559549 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer.

    Ito K, Utsunomiya H, Yaegashi N, Sasano H.

    Endocr J. 2007 Dec;54(5):667-79. Epub 2007 Sep 4. Review.PMID: 17785917 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hormonal therapy in ovarian cancer.

    Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S.

    Int J Gynecol Cancer. 2007 Mar-Apr;17(2):325-38. Review.PMID: 17362310 [PubMed - indexed for MEDLINE]Related articles

    6.

    Biology of female sex hormone action in relation to contraceptive agents and neoplasia.

    King RJ.

    Contraception. 1991 Jun;43(6):527-42. Review.PMID: 1651204 [PubMed - indexed for MEDLINE]Related articles

    7.

    Estrogens and epithelial ovarian cancer.

    Cunat S, Hoffmann P, Pujol P.

    Gynecol Oncol. 2004 Jul;94(1):25-32. Review.PMID: 15262115 [PubMed - indexed for MEDLINE]Related articles

    8.

    High-dose estrogen and clinical selective estrogen receptor modulators induce growth arrest, p21, and p53 in primate ovarian surface epithelial cells.

    Wright JW, Stouffer RL, Rodland KD.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3688-95. Epub 2005 Mar 8.PMID: 15755852 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.

    Risch HA.

    J Natl Cancer Inst. 1998 Dec 2;90(23):1774-86. Review.PMID: 9839517 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.

    Persson I.

    J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):357-64. Review.PMID: 11162945 [PubMed - indexed for MEDLINE]Related articles

    11.

    Aromatase in the context of breast and endometrial cancer. A review.

    Jongen VH, Hollema H, Van Der Zee AG, Heineman MJ.

    Minerva Endocrinol. 2006 Mar;31(1):47-60. Review.PMID: 16498363 [PubMed - indexed for MEDLINE]Related articles

    12.

    Estrogen stimulation of ovarian surface epithelial cell proliferation.

    Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV.

    In Vitro Cell Dev Biol Anim. 2000 Nov-Dec;36(10):657-66.PMID: 11229598 [PubMed - indexed for MEDLINE]Related articles

    13.

    Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.

    Runnebaum IB, Brüning A.

    Clin Cancer Res. 2005 Sep 1;11(17):6325-32.PMID: 16144937 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Hormonal treatments and epithelial ovarian cancer risk.

    Auranen A, Hietanen S, Salmi T, Grénman S.

    Int J Gynecol Cancer. 2005 Sep-Oct;15(5):692-700. Review.PMID: 16174215 [PubMed - indexed for MEDLINE]Related articles

    15.

    Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

    Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F.

    J Steroid Biochem Mol Biol. 2005 Jul;96(2):95-108. Review.PMID: 15908197 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.

    Syed V, Mukherjee K, Godoy-Tundidor S, Ho SM.

    J Cell Biochem. 2007 Oct 1;102(2):442-52.PMID: 17393432 [PubMed - indexed for MEDLINE]Related articles

    17.

    Proliferation of rhesus ovarian surface epithelial cells in culture: lack of mitogenic response to steroid or gonadotropic hormones.

    Wright JW, Toth-Fejel S, Stouffer RL, Rodland KD.

    Endocrinology. 2002 Jun;143(6):2198-207.PMID: 12021183 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hormonal therapy in epithelial ovarian cancer.

    Rao GG, Miller DS.

    Expert Rev Anticancer Ther. 2006 Jan;6(1):43-7. Review.PMID: 16375643 [PubMed - indexed for MEDLINE]Related articles

    19.

    Steroid hormones and cancer: (III) observations from human subjects.

    Miller WR, Langdon SP.

    Eur J Surg Oncol. 1997 Apr;23(2):163-77; quiz 177-8, 183. Review.PMID: 9158194 [PubMed - indexed for MEDLINE]Related articles

    20.

    Thyroid hormone signaling in human ovarian surface epithelial cells.

    Rae MT, Gubbay O, Kostogiannou A, Price D, Critchley HO, Hillier SG.

    J Clin Endocrinol Metab. 2007 Jan;92(1):322-7. Epub 2006 Oct 10.PMID: 17032711 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk